Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPISSOC
2025-524697-42-00Phase 3Authorised
- Sponsor
- CHU Amiens-Picardie
- Start
- May 2026
- Countries
- 1
01
Overview
Phase 3, randomised trial of sodium chloride in pleural abscess (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Treatment failure at 30 days. Planned start May 2026; status: authorised.
02
Drugs
sodium chloride
03
Conditions
pleural abscess
Beyond the preview
Go deeper on 2025-524697-42-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524697-42-00.